| DIRECT COMPETITOR COMPARISON | |
| AVXT.PK | AGEN | DNDN | Pvt1 | Industry | | Market Cap: | N/A | 63.27M | 3.07B | N/A | N/A | | Employees: | N/A | 80 | 198 | 4881 | N/A | | Qtrly Rev Growth (yoy): | N/A | 31.00% | -3.80% | N/A | N/A | | Revenue (ttm): | N/A | 3.31M | 108.00K | 52.30M1 | N/A | | Gross Margin (ttm): | N/A | 100.00% | 100.00% | N/A | N/A | | EBITDA (ttm): | N/A | -24.94M | -74.09M | N/A | N/A | | Oper Margins (ttm): | N/A | -881.51% | -72,917.59% | N/A | N/A | | Net Income (ttm): | N/A | -26.79M | -196.49M | -38.50M1 | N/A | | EPS (ttm): | N/A | -0.366 | -1.915 | N/A | N/A | | P/E (ttm): | N/A | N/A | N/A | N/A | N/A | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | N/A | | P/S (ttm): | N/A | 18.98 | 27932.23 | N/A | N/A |
|
| NEWS ON DIRECT COMPETITORS | |
| • | AGEN | | Mentor Capital Cancer Vaccine Investing Update
Wed, Dec 23 -
at Seeking Alpha | | • | DNDN | | Ten Predictions for 2010
Tue, Dec 22 -
at The Wall Street Journal Online | | • | DNDN | | 3 Reasons to Sell Dendreon Today
Fri, Dec 18 -
at Motley Fool | | • | DNDN | | 3 Reasons to Buy Dendreon Today
Fri, Dec 18 -
at Motley Fool | | • | AGEN | | Biotech Stock Mailbag: Year in Review
Fri, Dec 18 -
at TheStreet.com | | • | DNDN | | Five Biotech Events to Watch in 2010
Wed, Dec 16 -
at TheStreet.com | | • | DNDN | | Five Biotech Events to Watch in 2010
Wed, Dec 16 -
TheStreet.com | | • | DNDN | | What Will Be the Best Stock for 2010?
Tue, Dec 15 -
at Motley Fool | | • | AGEN | | Still Believe in Antigenics
Tue, Nov 24 -
at Seeking Alpha | | • | AGEN | | Antigenics pulls European Oncophage application
Fri, Nov 20 -
AP | | • | AGEN | | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Fri, Nov 20 -
EDGAR Online | | • | AGEN | | European CHMP Formally Adopts Negative Opinion on Oncophage®
Fri, Nov 20 -
Business Wire | | • | AGEN | | ANTIGENICS INC /DE/ Financials
Fri, Nov 13 -
EDGAR Online Financials | | | All Headlines for these symbols... |
|
|
|
0.51% Nasdaq 
Competitors
